Gerald T Proehl insider trades
Open-market stock purchases and sales by Gerald T Proehl, Director at Tenax Therapeutics, Inc, from SEC Form 4 filings since Mar 10, 2010.
Track record: 33% of 6 scored buys are up 5% or more since purchase, averaging -41%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 9, 2026 | TENX Tenax Therapeutics, Inc | Bought (not open market) | — |
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | — |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | $1M |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | $250K |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc | Sold (not open market) | $1M |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | $161K |
Companies traded
- TENX Tenax Therapeutics, Inc: 5 buys, last Jan 9, 2026
- DRMA Dermata Therapeutics, Inc: 3 buys, last Jan 2, 2026
- SPHS Sophiris BIO Inc: 1 buy, last Jun 27, 2019
- RTTR Ritter Pharmaceuticals Inc: 1 buy, last Jan 23, 2018
- ASPX Auspex Pharmaceuticals, Inc: 1 buy, last May 5, 2015
- SNTS Santarus Inc: 8 sales, last Jan 2, 2014